8月7日早间银诺医药在港交所公告公司拟全球发售36,556,400股H股香港发售股份3,655,800股国际发售股份32

智通财经
Aug 07
8月7日早间银诺医药在港交所公告公司拟全球发售36,556,400股H股香港发售股份3,655,800股国际发售股份32,900,600股H股另有15%的超额配股权;发售价每股H股18.68港元;预期H股股份将于2025年8月15日(星期五)开始在香港联交所买卖。公司预计全球发售净所得款项总额将约为6.101亿港元约90.0%将用于正在进行及计划中的临床试验以及核心产品依苏帕格鲁肽α的计划商业化上市;约10.0%将用于营运资金及一般公司用途。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10